Zevra Therapeutics (ZVRA) Current Leases (2014 - 2026)
Zevra Therapeutics (ZVRA) posted Current Leases of $214,000 for Q4 2018, up 13.2% from $189,000 a year earlier and up 1.9% from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) Current Leases (2014 - 2026) Analysis & Trends
Since Q4 2014, Zevra Therapeutics has reported Current Leases for 17 quarters.
- Annual Current Leases has increased for three consecutive years, with a four-year compound annual growth rate of 60.8% (FY2014 to FY2018).
- In prior years, Zevra Therapeutics' Current Leases was $189,000 in FY2017 (+20.4%), $157,000 in FY2016 (+503.8%), $26,000 in FY2015 (-18.8%) and $32,000 in FY2014.
- The Q4 2018 figure stands as the highest quarterly Current Leases in data going back to Q4 2014.
- On a year-over-year basis, Current Leases has increased in each of the last 11 quarters, with growth averaging 127.0% over the last eight quarters.
- The strongest year-over-year quarter for Current Leases in the past five years was Q1 2017, with growth of 800.0%; the weakest was Q1 2016, with a decline of 43.8%.
- According to Business Quant data, Current Leases for the three prior quarters was $210,000 (Q3 2018), $190,000 (Q2 2018) and $187,000 (Q1 2018).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Zevra Therapeutics | 708.52 Mn | -100.24 Mn | 36.01 Mn | 626,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 626,000.00 |
| Jun 30, 2026 | 626,000.00 |
| Mar 31, 2026 | 406,000.00 |
| Dec 31, 2025 | 419,000.00 |
| Sep 30, 2025 | 441,000.00 |
| Jun 30, 2025 | 525,000.00 |
| Mar 31, 2025 | 589,000.00 |
| Dec 31, 2024 | 420,000.00 |
| Sep 30, 2024 | 540,000.00 |
| Jun 30, 2024 | 596,000.00 |
| Mar 31, 2024 | 583,000.00 |
| Dec 31, 2023 | 543,000.00 |
| Sep 30, 2023 | 433,000.00 |
| Jun 30, 2023 | -3,000.00 |
| Mar 31, 2023 | 470,000.00 |
| Dec 31, 2022 | 480,000.00 |
| Sep 30, 2022 | 474,000.00 |
| Jun 30, 2022 | 469,000.00 |
| Mar 31, 2022 | 480,000.00 |
| Dec 31, 2021 | 356,000.00 |
API Access
Zevra Therapeutics Current Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-leases&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-leases", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-leases&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();